Selected research
Market Analysis & Forecast
Global IV Administration Primary Set Market Analysis and Forecast 2026-2032
Market perspective
The global IV Administration Primary Set market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for IV Administration Primary Set is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for IV Administration Primary Set is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for IV Administration Primary Set is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for IV Administration Primary Set is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of IV Administration Primary Set include BD, SB Kawasumi, Amsino, Bayer, Baxter International, Zyno Medical, Smiths Medical, MPS Medical and Medtec Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for IV Administration Primary Set, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of IV Administration Primary Set, also provides the sales of main regions and countries. Of the upcoming market potential for IV Administration Primary Set, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the IV Administration Primary Set sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IV Administration Primary Set market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for IV Administration Primary Set sales, projected growth trends, production technology, application and end-user industry.
IV Administration Primary Set Segment by Company
BD
SB Kawasumi
Amsino
Bayer
Baxter International
Zyno Medical
Smiths Medical
MPS Medical
Medtec Medical
MedSource Labs
ICU Medical
Eitan Group
CODAN US Corporation
B. Braun
Advanced Medical Systems
3M
IV Administration Primary Set Segment by Type
1 - 200 Micron
More Than 200 Micron
Less Than 1 Micron
IV Administration Primary Set Segment by Application
Hospitals
Clinics
Other
IV Administration Primary Set Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IV Administration Primary Set market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IV Administration Primary Set and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IV Administration Primary Set.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of IV Administration Primary Set in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of IV Administration Primary Set manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IV Administration Primary Set sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1 - 200 Micron
- More Than 200 Micron
- Less Than 1 Micron
Applications
- Hospitals
- Clinics
- Other
Companies covered
- BD
- SB Kawasumi
- Amsino
- Bayer
- Baxter International
- Zyno Medical
- Smiths Medical
- MPS Medical
- Medtec Medical
- MedSource Labs
- ICU Medical
- Eitan Group
- CODAN US Corporation
- B. Braun
- Advanced Medical Systems
- 3M
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 IV Administration Primary Set Market by Type
- 1.2.1 Global IV Administration Primary Set Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 1 - 200 Micron
- 1.2.3 More Than 200 Micron
- 1.2.4 Less Than 1 Micron
- 1.3 IV Administration Primary Set Market by Application
- 1.3.1 Global IV Administration Primary Set Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 IV Administration Primary Set Market Dynamics
- 2.1 IV Administration Primary Set Industry Trends
- 2.2 IV Administration Primary Set Industry Drivers
- 2.3 IV Administration Primary Set Industry Opportunities and Challenges
- 2.4 IV Administration Primary Set Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global IV Administration Primary Set Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global IV Administration Primary Set Revenue by Region
- 3.2.1 Global IV Administration Primary Set Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global IV Administration Primary Set Revenue by Region (2021-2026)
- 3.2.3 Global IV Administration Primary Set Revenue by Region (2027-2032)
- 3.2.4 Global IV Administration Primary Set Revenue Market Share by Region (2021-2032)
- 3.3 Global IV Administration Primary Set Sales Estimates and Forecasts 2021-2032
- 3.4 Global IV Administration Primary Set Sales by Region
- 3.4.1 Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global IV Administration Primary Set Sales by Region (2021-2026)
- 3.4.3 Global IV Administration Primary Set Sales by Region (2027-2032)
- 3.4.4 Global IV Administration Primary Set Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global IV Administration Primary Set Revenue by Manufacturers
- 4.1.1 Global IV Administration Primary Set Revenue by Manufacturers (2021-2026)
- 4.1.2 Global IV Administration Primary Set Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global IV Administration Primary Set Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global IV Administration Primary Set Sales by Manufacturers
- 4.2.1 Global IV Administration Primary Set Sales by Manufacturers (2021-2026)
- 4.2.2 Global IV Administration Primary Set Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global IV Administration Primary Set Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global IV Administration Primary Set Sales Price by Manufacturers (2021-2026)
- 4.4 Global IV Administration Primary Set Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global IV Administration Primary Set Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global IV Administration Primary Set Manufacturers, Product Type & Application
- 4.7 Global IV Administration Primary Set Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global IV Administration Primary Set Market CR5 and HHI
- 4.8.2 2025 IV Administration Primary Set Tier 1, Tier 2, and Tier 3
5 IV Administration Primary Set Market by Type
- 5.1 Global IV Administration Primary Set Revenue by Type
- 5.1.1 Global IV Administration Primary Set Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global IV Administration Primary Set Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global IV Administration Primary Set Revenue Market Share by Type (2021-2032)
- 5.2 Global IV Administration Primary Set Sales by Type
- 5.2.1 Global IV Administration Primary Set Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global IV Administration Primary Set Sales by Type (2021-2032) & (k units)
- 5.2.3 Global IV Administration Primary Set Sales Market Share by Type (2021-2032)
- 5.3 Global IV Administration Primary Set Price by Type
6 IV Administration Primary Set Market by Application
- 6.1 Global IV Administration Primary Set Revenue by Application
- 6.1.1 Global IV Administration Primary Set Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global IV Administration Primary Set Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global IV Administration Primary Set Revenue Market Share by Application (2021-2032)
- 6.2 Global IV Administration Primary Set Sales by Application
- 6.2.1 Global IV Administration Primary Set Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global IV Administration Primary Set Sales by Application (2021-2032) & (k units)
- 6.2.3 Global IV Administration Primary Set Sales Market Share by Application (2021-2032)
- 6.3 Global IV Administration Primary Set Price by Application
7 Company Profiles
- 7.1 BD
- 7.1.1 BD Company Information
- 7.1.2 BD Business Overview
- 7.1.3 BD IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 BD IV Administration Primary Set Product Portfolio
- 7.1.5 BD Recent Developments
- 7.2 SB Kawasumi
- 7.2.1 SB Kawasumi Company Information
- 7.2.2 SB Kawasumi Business Overview
- 7.2.3 SB Kawasumi IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 SB Kawasumi IV Administration Primary Set Product Portfolio
- 7.2.5 SB Kawasumi Recent Developments
- 7.3 Amsino
- 7.3.1 Amsino Company Information
- 7.3.2 Amsino Business Overview
- 7.3.3 Amsino IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Amsino IV Administration Primary Set Product Portfolio
- 7.3.5 Amsino Recent Developments
- 7.4 Bayer
- 7.4.1 Bayer Company Information
- 7.4.2 Bayer Business Overview
- 7.4.3 Bayer IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Bayer IV Administration Primary Set Product Portfolio
- 7.4.5 Bayer Recent Developments
- 7.5 Baxter International
- 7.5.1 Baxter International Company Information
- 7.5.2 Baxter International Business Overview
- 7.5.3 Baxter International IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Baxter International IV Administration Primary Set Product Portfolio
- 7.5.5 Baxter International Recent Developments
- 7.6 Zyno Medical
- 7.6.1 Zyno Medical Company Information
- 7.6.2 Zyno Medical Business Overview
- 7.6.3 Zyno Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Zyno Medical IV Administration Primary Set Product Portfolio
- 7.6.5 Zyno Medical Recent Developments
- 7.7 Smiths Medical
- 7.7.1 Smiths Medical Company Information
- 7.7.2 Smiths Medical Business Overview
- 7.7.3 Smiths Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Smiths Medical IV Administration Primary Set Product Portfolio
- 7.7.5 Smiths Medical Recent Developments
- 7.8 MPS Medical
- 7.8.1 MPS Medical Company Information
- 7.8.2 MPS Medical Business Overview
- 7.8.3 MPS Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 MPS Medical IV Administration Primary Set Product Portfolio
- 7.8.5 MPS Medical Recent Developments
- 7.9 Medtec Medical
- 7.9.1 Medtec Medical Company Information
- 7.9.2 Medtec Medical Business Overview
- 7.9.3 Medtec Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Medtec Medical IV Administration Primary Set Product Portfolio
- 7.9.5 Medtec Medical Recent Developments
- 7.10 MedSource Labs
- 7.10.1 MedSource Labs Company Information
- 7.10.2 MedSource Labs Business Overview
- 7.10.3 MedSource Labs IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 MedSource Labs IV Administration Primary Set Product Portfolio
- 7.10.5 MedSource Labs Recent Developments
- 7.11 ICU Medical
- 7.11.1 ICU Medical Company Information
- 7.11.2 ICU Medical Business Overview
- 7.11.3 ICU Medical IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 ICU Medical IV Administration Primary Set Product Portfolio
- 7.11.5 ICU Medical Recent Developments
- 7.12 Eitan Group
- 7.12.1 Eitan Group Company Information
- 7.12.2 Eitan Group Business Overview
- 7.12.3 Eitan Group IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Eitan Group IV Administration Primary Set Product Portfolio
- 7.12.5 Eitan Group Recent Developments
- 7.13 CODAN US Corporation
- 7.13.1 CODAN US Corporation Company Information
- 7.13.2 CODAN US Corporation Business Overview
- 7.13.3 CODAN US Corporation IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 CODAN US Corporation IV Administration Primary Set Product Portfolio
- 7.13.5 CODAN US Corporation Recent Developments
- 7.14 B. Braun
- 7.14.1 B. Braun Company Information
- 7.14.2 B. Braun Business Overview
- 7.14.3 B. Braun IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 B. Braun IV Administration Primary Set Product Portfolio
- 7.14.5 B. Braun Recent Developments
- 7.15 Advanced Medical Systems
- 7.15.1 Advanced Medical Systems Company Information
- 7.15.2 Advanced Medical Systems Business Overview
- 7.15.3 Advanced Medical Systems IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Advanced Medical Systems IV Administration Primary Set Product Portfolio
- 7.15.5 Advanced Medical Systems Recent Developments
- 7.16 3M
- 7.16.1 3M Company Information
- 7.16.2 3M Business Overview
- 7.16.3 3M IV Administration Primary Set Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.16.4 3M IV Administration Primary Set Product Portfolio
- 7.16.5 3M Recent Developments
8 North America
- 8.1 North America IV Administration Primary Set Market Size by Type
- 8.1.1 North America IV Administration Primary Set Revenue by Type (2021-2032)
- 8.1.2 North America IV Administration Primary Set Sales by Type (2021-2032)
- 8.1.3 North America IV Administration Primary Set Price by Type (2021-2032)
- 8.2 North America IV Administration Primary Set Market Size by Application
- 8.2.1 North America IV Administration Primary Set Revenue by Application (2021-2032)
- 8.2.2 North America IV Administration Primary Set Sales by Application (2021-2032)
- 8.2.3 North America IV Administration Primary Set Price by Application (2021-2032)
- 8.3 North America IV Administration Primary Set Market Size by Country
- 8.3.1 North America IV Administration Primary Set Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America IV Administration Primary Set Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America IV Administration Primary Set Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe IV Administration Primary Set Market Size by Type
- 9.1.1 Europe IV Administration Primary Set Revenue by Type (2021-2032)
- 9.1.2 Europe IV Administration Primary Set Sales by Type (2021-2032)
- 9.1.3 Europe IV Administration Primary Set Price by Type (2021-2032)
- 9.2 Europe IV Administration Primary Set Market Size by Application
- 9.2.1 Europe IV Administration Primary Set Revenue by Application (2021-2032)
- 9.2.2 Europe IV Administration Primary Set Sales by Application (2021-2032)
- 9.2.3 Europe IV Administration Primary Set Price by Application (2021-2032)
- 9.3 Europe IV Administration Primary Set Market Size by Country
- 9.3.1 Europe IV Administration Primary Set Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe IV Administration Primary Set Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe IV Administration Primary Set Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China IV Administration Primary Set Market Size by Type
- 10.1.1 China IV Administration Primary Set Revenue by Type (2021-2032)
- 10.1.2 China IV Administration Primary Set Sales by Type (2021-2032)
- 10.1.3 China IV Administration Primary Set Price by Type (2021-2032)
- 10.2 China IV Administration Primary Set Market Size by Application
- 10.2.1 China IV Administration Primary Set Revenue by Application (2021-2032)
- 10.2.2 China IV Administration Primary Set Sales by Application (2021-2032)
- 10.2.3 China IV Administration Primary Set Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia IV Administration Primary Set Market Size by Type
- 11.1.1 Asia IV Administration Primary Set Revenue by Type (2021-2032)
- 11.1.2 Asia IV Administration Primary Set Sales by Type (2021-2032)
- 11.1.3 Asia IV Administration Primary Set Price by Type (2021-2032)
- 11.2 Asia IV Administration Primary Set Market Size by Application
- 11.2.1 Asia IV Administration Primary Set Revenue by Application (2021-2032)
- 11.2.2 Asia IV Administration Primary Set Sales by Application (2021-2032)
- 11.2.3 Asia IV Administration Primary Set Price by Application (2021-2032)
- 11.3 Asia IV Administration Primary Set Market Size by Country
- 11.3.1 Asia IV Administration Primary Set Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia IV Administration Primary Set Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia IV Administration Primary Set Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA IV Administration Primary Set Market Size by Type
- 12.1.1 SAMEA IV Administration Primary Set Revenue by Type (2021-2032)
- 12.1.2 SAMEA IV Administration Primary Set Sales by Type (2021-2032)
- 12.1.3 SAMEA IV Administration Primary Set Price by Type (2021-2032)
- 12.2 SAMEA IV Administration Primary Set Market Size by Application
- 12.2.1 SAMEA IV Administration Primary Set Revenue by Application (2021-2032)
- 12.2.2 SAMEA IV Administration Primary Set Sales by Application (2021-2032)
- 12.2.3 SAMEA IV Administration Primary Set Price by Application (2021-2032)
- 12.3 SAMEA IV Administration Primary Set Market Size by Country
- 12.3.1 SAMEA IV Administration Primary Set Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA IV Administration Primary Set Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA IV Administration Primary Set Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 IV Administration Primary Set Value Chain Analysis
- 13.1.1 IV Administration Primary Set Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 IV Administration Primary Set Production Mode & Process
- 13.2 IV Administration Primary Set Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 IV Administration Primary Set Distributors
- 13.2.3 IV Administration Primary Set Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst